Dallas, TX -- (SBWire) -- 11/23/2010 -- SandlerResearch announce it will carry Brain Hemorrhage Therapeutics – Pipeline Assessment and Market Forecasts to 2017 Market Research Report in its Store.
GlobalData, the industry analysis specialist, has released its new report, “Brain Hemorrhage Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global brain hemorrhage therapeutics market. The report identifies the key trends shaping and driving the global brain hemorrhage therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global brain hemorrhage therapeutics sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
GlobalData estimates that the global brain hemorrhage market was valued at $540m in 2009 and forecasts it to grow at a Compound Annual Growth Rate (CAGR) of 6.1% to reach $868m by 2017. This modest growth forecast is primarily attributed to a weak pipeline landscape. The existing market is weak due to lack of targeted therapies, poor awareness levels of the condition and the poor safety profiles of the existing therapies. The market is characterized by several off-label drugs and generics that treat the symptoms of the condition. Antihypertensive agents, antiepileptic agents, stool softeners, antidotes and analgesics are the most commonly employed therapies to treat the condition symptomatically.
Scope
The report provides information on the key drivers and challenges of the brain hemorrhage therapeutics market. Its scope includes:
- Annualized global brain hemorrhage therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as acetylcholine reducers, adrenergic reuptake inhibitors, antioxidants, 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase) inhibitors, iron chelators, nitric oxide releasing agents and calcium channel blockers.
- Analysis of the current and future competition in the global brain hemorrhage market. Key market players covered are F. Hoffmann-La Roche Ltd, and Baxter International Inc
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the brain hemorrhage therapeutics market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global brain hemorrhage therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global brain hemorrhage therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global brain hemorrhage therapeutics market landscape? – Identify, understand and capitalize.
Browse complete Report on: Brain Hemorrhage Therapeutics – Pipeline Assessment and Market Forecasts to 2017 http://www.sandlerresearch.org/reports/41250-brain-hemorrhage-therapeutics-pipeline-assessment-and-market-fo.html
1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Brain Hemorrhage: Market Characterization 5
2.1 Overview 5
2.1.1 Intracerebral Hemorrhage 5
2.1.2 Subarachnoid Hemorrhage 5
2.1.3 GlobalData Pipeline Report Guidance 6
2.2 Brain Hemorrhage Market Size 7
2.3 Brain Hemorrhage Market Forecast and CAGR 8
2.4 Drivers and Barriers for Brain Hemorrhage Market 10
2.4.1 Drivers for Brain Hemorrhage Market 10
2.4.2 Barriers for Brain Hemorrhage Market 10
2.5 Opportunity and Unmet Need 10
2.6 Key Takeaway 12
3 Brain Hemorrhage Market: Competitive Assessment 13
3.1 Overview 13
3.2 Strategic Competitor Assessment 14
3.3 Major Therapies in the Brain Hemorrhage Market 15
3.3.1 Antihypertensive Agents 15
3.3.2 Antiepileptic Agents 15
3.3.3 Analgesics and NSAID 16
3.4 Key Takeaway 17
4 Brain Hemorrhage Market: Pipeline Assessment 18
4.1 Overview 18
4.2 Strategic Pipeline Assessment 18
4.2.1 Technology Trends Analytic Framework 18
4.3 Brain Hemorrhage Therapeutics – Promising Drugs Under Clinical Development 20
4.4 Molecule Profile for Promising Drugs Under Clinical Development 21
4.4.1 Cathflo Activase (Alteplase) 21
4.5 Brain Hemorrhage Therapeutics Market – Clinical Pipeline by Therapeutic Class 22
4.6 Brain Hemorrhage Pipeline, Pipeline by Clinical Phases of Development 23
4.6.1 Brain Hemorrhage Therapeutics, Phase III Clinical Pipeline 23
4.6.2 Brain Hemorrhage Therapeutics – Phase II Clinical Pipeline 24
4.6.3 Brain Hemorrhage Therapeutics, Phase I Clinical Pipeline 24
4.7 Key Takeaway 24
5 Global Brain Hemorrhage Market: Implications for Future Market Competition 25
6 Global Brain Hemorrhage Market: Future Players in the Brain Hemorrhage Market 26
6.1 Introduction 26
6.2 F. Hoffmann-La Roche Ltd. 27
6.2.1 Company Overview 27
6.2.2 Cathflo Activase (Alteplase) 28
6.3 Baxter International Inc. 29
6.3.1 Company Overview 29
7 Global Brain Hemorrhage Market: Appendix 31
7.1 Definitions 31
7.2 Acronyms 31
7.3 Research Methodology 32
7.3.1 Coverage 32
7.3.2 Secondary Research 32
7.3.3 Forecasting 32
7.3.4 Primary Research 35
7.3.5 Expert Panels 35
7.4 Contact Us 35
7.5 Disclaimer 35
7.6 Sources 36
Browse all Healthcare Market Research Reports on:
http://www.sandlerresearch.org/market-research/healthcare/
Browse all GlobalData Market Research Reports on:
http://www.sandlerresearch.org/publishers/globaldata/
Browse all Newly Published Market Research Reports on:
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports:
Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/41343-epilepsy-therapeutics-pipeline-assessment-and-market-forecasts-.html
Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017http://www.sandlerresearch.org/reports/36584-influenza-vaccines-pipeline-assessment-and-market-forecasts-to-.html
Acute Myeloid Leukemia (AML) - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/39673-acute-myeloid-leukemia-aml-pipeline-assessment-and-market-for.html
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
http://www.sandlerresearch.org/reports/36585-head-and-neck-cancer-pipeline-assessment-and-market-forecast-to.html
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/37160-rheumatoid-arthritis-pipeline-assessment-and-market-forecasts-t.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.com
Brain Hemorrhage Therapeutics – Pipeline Assessment and Market Forecasts to 2017 Now Available at SandlerResearch